Skip to main content
. 2021 Apr 21;2021:5555613. doi: 10.1155/2021/5555613

Figure 2.

Figure 2

(a) CXR-PA taken on day 3 of illness (showing widespread opacities in both lung fields) and (b) on day 5 of illness (normal).